Glenmark launches biosimilar of anti-diabetic drug, vows to cut down therapy cost by 70% : vimarsana.com

Priced at around Rs 100 for a standard dose of 1.2 mg (per day), this will lower the cost of therapy by approximately 70 percent

Related Keywords

India , United States , American , Alok Malik , Glenmark Life Sciences , American Diabetes Association , Glenmark Pharmaceuticals Ltd , Glenmark Pharmaceuticals , Drug Controller General , Glenmark Life , Glenmark , Iraglutide , Roduct Launch , Ndia , Iabetes ,